Key result
Thermoregulation dysfunction links to worse angina-related quality of life in metabolic syndrome.
Why the study?
Less is known about how thermoregulation dysfunction relates to cardiovascular symptom burden in patients with metabolic syndrome.
Cross-Sectional (n=603)
Yes
Perceived thermoregulation dysfunction is associated with a greater burden of cardiovascular symptoms in patients with metabolic syndrome.
Background: Metabolic syndrome (MetS), as a clustering of health disorders, has been linked to the onset of cardiovascular disease. Less is known about how flexible the body is in controlling its own temperature. If this system doesn't work right, it can add stress on the heart and blood vessels. Objective: To investigate the relationship between symptoms of thermoregulation dysfunction and cardiovascular symptom burden among MetS patients in various countries. Methods: A cross-sectional questionnaire survey among 603 adult MetS patients from Pakistan, the United Kingdom and the United Arab Emirates. Perceived thermoregulation dysfunction was evaluated with the secretomotor scale of the Composite Autonomic Symptom Score (COMPASS-31), and cardiovascular symptoms were determined with the Seattle Angina Questionnaire (SAQ). Correlations, Mann-Whitney U tests, Kruskal-Wallis tests and multiple regression were used as statistical tests. Results: People with MetS who have difficulty regulating their temperature seem to carry a greater burden of cardiovascular symptoms. Management in these patients may benefit from addressing thermal and autonomic issues.
No takes yet. Share an insight, caveat, or question.
Mashayekhi et al. (2026) conducted a cross-sectional in Metabolic syndrome (n=603). Perceived thermoregulation dysfunction vs. Lower perceived thermoregulation dysfunction was evaluated on Cardiovascular symptom burden (Seattle Angina Questionnaire score) (ρ = -0.350, p=<0.001). Higher perceived thermoregulation dysfunction was significantly associated with a greater burden of cardiovascular symptoms and worse angina-related quality of life (ρ = -0.350, p < 0.001) in patients with metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: